| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 52.769.920 $ | +5.722.195 $ | -19,8 % | 6 | 109.495.134 $ | +109.495.134 $ | 11 | |||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 29.445.086 $ | +7.518.167 $ | +34,3 % | 1 | 21.926.919 $ | +21.926.919 $ | 1 | |
| Verastem, Inc. | VSTM | → 0 | Neutral | 15.440.000 $ | +15.440.000 $ | 1 | |||||
| AmpliTech Group, Inc. | AMPG | → 0 | Neutral | 13.234.900 $ | +13.234.900 $ | 1 | |||||
| Inventiva S.A. | IVA | → 0 | Schwach | 13.064.700 $ | +974.700 $ | +8,1 % | 1 | 12.090.000 $ | +12.090.000 $ | 1 | |
| PRECIGEN, INC. | PGEN | → 0 | Schwach | 12.540.000 $ | +12.540.000 $ | 1 | |||||
| Nuvation Bio Inc. | NUVB | → 0 | Sehr schwach | 11.200.000 $ | +11.200.000 $ | 1 | |||||
| Rani Therapeutics Holdings, Inc. | RANI | → 0 | Neutral | 2.694.941 $ | -5.810.059 $ | -68,3 % | 1 | 8.505.000 $ | +8.505.000 $ | 1 | |
| Aardvark Therapeutics, Inc. | AARD | → 0 | Neutral | 6.255.309 $ | +6.255.309 $ | 1 | |||||
| Wave Life Sciences Ltd. | WVE | → 0 | Neutral | 5.437.500 $ | +5.437.500 $ | 1 | |||||
| Clene Inc. | CLNN | → 0 | Neutral | 2.125.293 $ | -2.397.513 $ | -53,0 % | 1 | 4.522.806 $ | +4.522.806 $ | 1 | |
| Generation Bio Co. | GBIO | → 0 | 3.777.200 $ | +3.777.200 $ | 1 | ||||||
| SURROZEN INC | → 0 | 2.400 $ | -600 $ | -20,0 % | 1 | 3.000 $ | +3.000 $ | 1 | |||
| 52.769.920 $ | +5.722.195 $ | -19,8 % | 6 | 109.495.134 $ | +109.495.134 $ | 11 | |||||